Cyclooxygenase-2 in cancer cells and macrophages induces colon cancer cell growth by cigarette smoke extract

Eur J Pharmacol. 2005 Jul 25;518(1):47-55. doi: 10.1016/j.ejphar.2005.05.018.

Abstract

Cigarette smoking, cyclooxygenase-2 (COX-2) and macrophages are independently associated with colorectal cancer. In the present study, cigarette smoke ethanol extract was applied to colon cancer cells (SW1116) or indirectly via activated macrophages (THP-1 cells) to attest their effects on cancer cell proliferation and tumor growth both in vitro and in vivo. Ethanol extract induced COX-2 expression in SW1116 and THP-1 cells. Combination of THP-1 pre-incubated medium and ethanol extract further potentiated COX-2 expression and proliferation of SW1116 cells. Tumor growth in nude mice was positively associated with the medium and/or ethanol extract treatments, together with the up-regulation of cell proliferation and angiogenesis, and down-regulation of apoptosis. Application of a COX-2 inhibitor (SC236) reduced tumor growth as well as cell proliferation and angiogenesis. These actions are partially depended on the decrease of COX-2 expression. Taken together, inhibition of COX-2 activity may have significant implication to prevent colon cancer in smokers.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Apoptosis / drug effects
  • Cell Line
  • Cell Line, Tumor
  • Cell Proliferation / drug effects*
  • Colonic Neoplasms / blood supply
  • Colonic Neoplasms / enzymology
  • Colonic Neoplasms / pathology
  • Complex Mixtures / chemistry
  • Complex Mixtures / pharmacology*
  • Cyclooxygenase 2
  • Cyclooxygenase 2 Inhibitors
  • Cyclooxygenase Inhibitors / pharmacology
  • Cyclooxygenase Inhibitors / therapeutic use
  • Dose-Response Relationship, Drug
  • Ethanol / chemistry
  • Humans
  • Macrophages / drug effects*
  • Macrophages / enzymology
  • Membrane Proteins
  • Mice
  • Mice, Nude
  • Neovascularization, Pathologic / metabolism
  • Neovascularization, Pathologic / pathology
  • Neovascularization, Pathologic / prevention & control
  • Nicotiana*
  • Prostaglandin-Endoperoxide Synthases / metabolism*
  • Proto-Oncogene Proteins c-bcl-2 / metabolism
  • Pyrazoles / pharmacology
  • Pyrazoles / therapeutic use
  • Smoke*
  • Sulfonamides / pharmacology
  • Sulfonamides / therapeutic use
  • Thymidine / metabolism
  • Time Factors
  • Tritium
  • Vascular Endothelial Growth Factor A / metabolism
  • Xenograft Model Antitumor Assays / methods

Substances

  • 4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide
  • Complex Mixtures
  • Cyclooxygenase 2 Inhibitors
  • Cyclooxygenase Inhibitors
  • Membrane Proteins
  • Proto-Oncogene Proteins c-bcl-2
  • Pyrazoles
  • Smoke
  • Sulfonamides
  • Vascular Endothelial Growth Factor A
  • Tritium
  • Ethanol
  • Cyclooxygenase 2
  • PTGS2 protein, human
  • Prostaglandin-Endoperoxide Synthases
  • Thymidine